Tracking a lifeline: Real-World survival data for frail blood cancer patients
NCT ID NCT05424562
Summary
This study aims to understand how well the approved drug venetoclax works in real-world settings for adults with acute myeloid leukemia (AML) who are too old or frail for standard intensive chemotherapy. It will follow about 200 patients across Canada for three years, collecting data on survival, remission rates, and quality of life during their normal treatment. The goal is to gather practical evidence on managing this aggressive blood cancer in vulnerable patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allan Blair Cancer Centre /ID# 247663
Regina, Saskatchewan, S4T 7T1, Canada
-
BC Cancer - Surrey /ID# 257515
Surrey, British Columbia, V3V 1Z2, Canada
-
BC Cancer - Victoria /ID# 257339
Victoria, British Columbia, V8R 6V5, Canada
-
CIUSSS de l'Estrie - CHUS /ID# 248915
Sherbrooke, Quebec, J1G 2E8, Canada
-
CancerCare Manitoba /ID# 246414
Winnipeg, Manitoba, R3E 0V9, Canada
-
Disc_Royal Victoria Hospital / McGill University Health Centre /ID# 249704
Montreal, Quebec, H4A 3J1, Canada
-
Eastern Regional Health Authority /ID# 250241
St. John's, Newfoundland and Labrador, A1B 3V6, Canada
-
Juravinski Cancer Centre /ID# 247183
Hamilton, Ontario, L8V 1C3, Canada
-
Kingston Health Sciences Centre /ID# 253439
Kingston, Ontario, K7L 2V7, Canada
-
Lakeridge Health - Oshawa /ID# 246412
Oshawa, Ontario, L1G 2B9, Canada
-
London Health Sciences Center- University Hospital /ID# 248027
London, Ontario, N6A 5W9, Canada
-
Queen Elizabeth II Health Sciences Centre - Victoria General /ID# 246514
Halifax, Nova Scotia, B3H 2Y9, Canada
-
Saskatoon Cancer Centre /ID# 247181
Saskatoon, Saskatchewan, S7N 4H4, Canada
-
Sunnybrook Health Sciences Centre /ID# 251966
Toronto, Ontario, M4N 3M5, Canada
-
The Moncton Hospital /ID# 247277
Moncton, New Brunswick, E1C 6Z8, Canada
-
Thunder Bay Regional Research Institute /ID# 249163
Thunder Bay, Ontario, P7B 6V4, Canada
-
Tom Baker Cancer Centre /ID# 248113
Calgary, Alberta, T2N 4N2, Canada
-
University Health Network_Princess Margaret Cancer Centre /ID# 249607
Toronto, Ontario, M5G 2M9, Canada
-
University of Alberta Hospital /ID# 251531
Edmonton, Alberta, T6G 2B7, Canada
-
Vancouver General Hospital /ID# 245438
Vancouver, British Columbia, V5Z 1M9, Canada
Conditions
Explore the condition pages connected to this study.